BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27172741)

  • 41. Impact of histology on prognosis of patients with early-stage cervical cancer treated with radical surgery.
    Rudtanasudjatum K; Charoenkwan K; Khunamornpong S; Siriaunkgul S
    Int J Gynaecol Obstet; 2011 Nov; 115(2):183-7. PubMed ID: 21885048
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of Twist enhances risk of poor oncologic outcome in patients with stage Ib to II cervical carcinoma with lymphovascular space involvement.
    Kajiyama H; Shibata K; Umezu T; Mizuno M; Suzuki S; Yamamoto E; Fujiwara S; Kikkawa F
    Hum Pathol; 2013 Feb; 44(2):181-8. PubMed ID: 22974479
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of criteria for ovarian preservation in cervical cancer patients treated with radical surgery with or without neoadjuvant chemotherapy: a multicenter retrospective study and meta-analysis.
    Hu T; Wu L; Xing H; Yang R; Li X; Huang K; Jia Y; Zhang Q; Chen Z; Wang S; Liu D; Han X; Lin Z; Qu P; Cai H; Song X; Tian X; Wang H; Wang S; Xie X; Li S; Ma D
    Ann Surg Oncol; 2013 Mar; 20(3):881-90. PubMed ID: 23054110
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Individualized prediction of overall survival after postoperative radiation therapy in patients with early-stage cervical cancer: a Korean Radiation Oncology Group study (KROG 13-03).
    Lee HJ; Han S; Kim YS; Nam JH; Kim HJ; Kim JW; Park W; Kim BG; Kim JH; Cha SD; Kim J; Lee KH; Yoon MS; Kim SM; Kim JY; Yoon WS; Lee NW; Choi JH; Park SY; Kim JY
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):659-64. PubMed ID: 24138914
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of Prognostic Factors Affecting the Outcome of Stage IB-IIB Cervical Cancer Treated by Radical Hysterectomy and Pelvic Lymphadenectomy.
    Xia X; Xu H; Wang Z; Liu R; Hu T; Li S
    Am J Clin Oncol; 2016 Dec; 39(6):604-608. PubMed ID: 24937635
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical analysis of 132 cases of cervical adenosquamous carcinoma and cervical adenocarcinoma].
    Meng YH; Li S; Hu T; Ma D; Lu YP; Wang H
    Chin J Cancer; 2010 Jan; 29(1):15-9. PubMed ID: 20038304
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic value of ABO blood group in patients with early stage cervical cancer treated with radical hysterectomy with pelvic node dissection.
    Hanprasertpong J; Jiamset I; Atjimakul T
    Tumour Biol; 2016 Jun; 37(6):7421-30. PubMed ID: 26678885
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic value of the number of the metastatic lymph nodes in locally early-stage cervical cancer: squamous cell carcinoma versus non-squamous cell carcinoma.
    Aslan K; Haberal A; Akıllı H; Meydanli MM; Ayhan A
    Arch Gynecol Obstet; 2021 Nov; 304(5):1279-1289. PubMed ID: 33772630
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases.
    Ferns DM; Heeren AM; Samuels S; Bleeker MCG; de Gruijl TD; Kenter GG; Jordanova ES
    J Immunother Cancer; 2016; 4():78. PubMed ID: 27895918
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Histology as Prognostic Factor in Early-Stage Cervical Carcinoma. Experience in a Third-Level Institution.
    Barquet-Muñoz SA; Cruz-Rodríguez E; Cantú De León DF; Isla-Ortiz D; Montalvo-Esquivel G; Herrera-Montalvo LA; Pérez-Plasencia C; Pérez-Montiel D; Herrera-Gómez Á
    Rev Invest Clin; 2017; 69(5):286-292. PubMed ID: 29077701
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Influence of tumor diameter on treatment results in cervical cancer patients].
    Jońska-Gmyrek J; Zółciak-Siwińska A; Gmyrek L; Staniaszek J; Lindner B; Andrzejuk J
    Ginekol Pol; 2012 Aug; 83(8):576-80. PubMed ID: 23342879
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
    Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinicopathologic factors for central recurrence in patients with locally advanced bulky cervical cancer.
    Lee WM; Park SI; Kim BJ; Kim MH; Choi SC; Lee ED; Ryu SY
    Eur J Obstet Gynecol Reprod Biol; 2012 Apr; 161(2):219-23. PubMed ID: 22326616
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of salvage therapies for isolated para-aortic lymph node recurrence in patients with uterine cervical cancer after definitive treatment.
    Kubota H; Tsujino K; Sulaiman NS; Sekii S; Matsumoto Y; Ota Y; Soejima T; Yamaguchi S; Sasaki R
    Radiat Oncol; 2019 Dec; 14(1):236. PubMed ID: 31878944
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic factors in definitive radiotherapy of uterine cervical cancer.
    Yalman D; Aras AB; Ozkök S; Duransoy A; Celik OK; Ozsaran Z; Haydaroğlu A
    Eur J Gynaecol Oncol; 2003; 24(3-4):309-14. PubMed ID: 12807246
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix?
    Shingleton HM; Bell MC; Fremgen A; Chmiel JS; Russell AH; Jones WB; Winchester DP; Clive RE
    Cancer; 1995 Nov; 76(10 Suppl):1948-55. PubMed ID: 8634986
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the efficacy of prophylactic extended field irradiation in the concomitant chemoradiotherapy treatment of locally advanced cervical cancer, stage IIIB in the 2018 FIGO classification.
    Meng Q; Liu X; Wang W; Hou X; Lian X; Sun S; Yan J; Liu Z; Miao Z; Hu K; Zhang F
    Radiat Oncol; 2019 Dec; 14(1):228. PubMed ID: 31842919
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk factors and prognosis of IB-IIB cervical carcinoma with common iliac lymph node metastasis.
    Huang L; Zheng M; Liu JH; Xiong Y; Ding H; Tang L; Wang HY
    Chin J Cancer; 2010 Apr; 29(4):431-5. PubMed ID: 20346221
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Prognosis and Risk Stratification Based on Pelvic Lymph Node Characteristics in Patients With Locally Advanced Cervical Squamous Cell Carcinoma Treated With Concurrent Chemoradiotherapy.
    Li X; Wei LC; Zhang Y; Zhao LN; Li WW; Ping LJ; Dang YZ; Hu J; Shi M
    Int J Gynecol Cancer; 2016 Oct; 26(8):1472-9. PubMed ID: 27400321
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinicopathological characteristics and prognosis of cervical cancer with different histological types: A population-based cohort study.
    Meng Y; Chu T; Lin S; Wu P; Zhi W; Peng T; Ding W; Luo D; Wu P
    Gynecol Oncol; 2021 Dec; 163(3):545-551. PubMed ID: 34740461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.